You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

ACEPHEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Acephen patents expire, and what generic alternatives are available?

Acephen is a drug marketed by Cosette and is included in four NDAs.

The generic ingredient in ACEPHEN is acetaminophen. There are sixty-six drug master file entries for this compound. Ninety suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Acephen

A generic version of ACEPHEN was approved as acetaminophen by PERRIGO on February 25th, 2000.

  Try a Trial

Summary for ACEPHEN
Drug patent expirations by year for ACEPHEN
Drug Prices for ACEPHEN

See drug prices for ACEPHEN

Drug Sales Revenue Trends for ACEPHEN

See drug sales revenues for ACEPHEN

Recent Clinical Trials for ACEPHEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of North Carolina, Chapel HillPhase 4

See all ACEPHEN clinical trials

US Patents and Regulatory Information for ACEPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 072218-001 Mar 27, 1992 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 018060-003 Dec 18, 1986 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 018060-001 Approved Prior to Jan 1, 1982 OTC No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 072344-001 Mar 27, 1992 OTC No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 018060-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.